While the FDA has issued recent guidance on CBD, many companies and stakeholders don’t believe it goes far enough. The regulatory agency plans to fill in current gaps in CBD research with more scientific evidence. According to the FDA, the goal is to strengthen safeguards in the market and protect consumer health. Over the years, the FDA has justified its lax position by claiming it didn’t have enough verified scientific evidence.

Push for More Research

With the new research, the FDA has signaled that they want to strengthen consumer safety. According to Hemp Today, the agency wrote in part that better data is “needed for the FDA and other public health agencies to make informed, science-based decisions that impact public health.” There are numerous reports about vendors violating current rules and possibly risking consumer health with outrageous claims. Dangerous practices combined with these claims have led many to believe the FDA is not taking a strong-enough regulatory stance.

What CBD Stakeholders Say

Prominent CBD proponents don’t think the new regulations adequately control the market. They say customers are still left vulnerable and unsafe products continue to reach the market. Steve Mister, the president of the Council for Responsible Nutrition, said the latest guidance is “nothing more than an end-of-administration desk-clearing exercise from an FDA that has failed to lead in this crucial policy area.”

Need for Greater Regulation

CBD supporters say current rules are inconsistent, varying among states. The lackluster regulations allow illegitimate CBD companies to sell potentially dangerous products. In turn, customers can’t differentiate between good and bad companies, leading to serious issues. Therefore, the need for a crackdown in the space, more comprehensive rules, and additional scientific evidence are the way forward for a better CBD experience for all.

Green Leaf for All Your Needs

Green Leaf is committed to providing customers with only the safest, highest quality products. There are plenty of great products to choose from, including tinctures, powders, and crystals.

Source:

https://hemptoday.net/update-on-cbd-criticized-as-doing-little-to-advance-u-s-regulation/